article_detail
Date Published: 13/04/2021
ARCHIVED - American health authorities put Janssen vaccine on hold due to blood clots
300,000 doses of the vaccine, which the EMA authorised last month, were due to arrive in Spain over the next couple of weeks.
The US's CDC (Centre for Disease Control and Prevention) and the FDA (Food and Drug Administration) have recommended that the use of the Covid-19 vaccine by Johnson & Johnson-Janssen be suspended as six cases have been reported of a rare and severe type of blood clot.
Spain was due to receive its first batch of the single-dose coronavirus vaccine by Janssen on Wednesday (14 April) with plans to use it to speed up innoculation of residents in their 70s and had been hoping to use the single dose vaccine to target this more vulnerable group and rapidly give them immunity.
This is wasanother major blow for the Spanish roll-out, which has been fraught with shortages and delivery problems. Today the anticipated weekly delivery of AstraZeneca contained only 40 per cent of the anticipated doses, causing problems for health authorities who had programmed vaccinations in anticipation of a larger supply of vaccine.
However, there are now some concerns over the safety of the vaccine, which have led the US authorities to recommend pausing its use as a precaution. The CDC has convened a special meeting for Wednesday to review and assess the cases.
As a precautionary measure, the company has decided to temporarily suspend the European roll-out.
Contact Spanish News Today: Editorial 966 260 896 /
Office 968 018 268